Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$20.49 - $39.72 $67,022 - $129,924
3,271 Added 92.19%
6,819 $146,000
Q1 2022

May 16, 2022

BUY
$28.19 - $46.6 $100,018 - $165,336
3,548 New
3,548 $131,000
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $260,466 - $465,299
-6,322 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $373,946 - $581,560
6,322 New
6,322 $401,000
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $27,224 - $40,200
-1,415 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $25,918 - $51,863
1,294 Added 1069.42%
1,415 $32,000
Q2 2019

Aug 14, 2019

SELL
$25.78 - $39.77 $2,268 - $3,499
-88 Reduced 42.11%
121 $4,000
Q1 2019

May 15, 2019

BUY
$22.09 - $39.21 $4,616 - $8,194
209 New
209 $7,000
Q4 2018

Feb 14, 2019

SELL
$19.89 - $30.02 $7,856 - $11,857
-395 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$12.1 - $28.85 $5,529 - $13,184
-457 Reduced 53.64%
395 $11,000
Q2 2018

Aug 14, 2018

BUY
$7.93 - $15.79 $6,756 - $13,453
852 New
852 $10,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.